In the context of existing literature based on the findings from the barriers to effective post-stroke comorbidity management in stroke survivors with diabetes COMPOSEd study (15) as a future strategy to ensure effective post-stroke diabetes management suggests incorporating pioglitazone into treatment protocols, given its potential benefits in improving insulin sensitivity and reducing cardiovascular risk factors in stroke survivors with diabetes. The gene discussed is INS; the disease is diabetes mellitus.